🔗 Visit the ClinicalTrials.gov page for NCT00006249
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. | Lancet | 2008 | 3.62 |
| 2 | Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. | Eur J Cancer | 2011 | 1.28 |